Unlike a varied spectrum of AEs in different types of cancers with other PD-1 inhibitors, the most common TRAEs in different cancer types were concentrated in reactive capillary hemangiomas (RCHs), pruritus, hypothyroidism, fatigue, and hypothyroidism. Here, PDCD1 is linked to cancer.